AKIP1 and breast carcinoma: Due to its function, AKIP1 has previously been reported to act as a potential oncogenic protein in various cancers such as esophageal squamous cell carcinoma (Lin et al., 2015), breast carcinoma (Mo et al., 2016), non-small-cell lung cancer (Guo et al., 2017) and colorectal cancer (Jiang et al., 2018).